Loxapine in patient with clozapine-resistant psychosis

• Main Authors: Jennifer Erley, PharmD, MBA, BCPS (Author), Sarah Goldsborough, PharmD (Author), Amy VandenBerg, PharmD, BCPP (Author), Alexandra Audu, MD (Author)
• Format: Book
• Published: American Association of Psychiatric Pharmacists, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Clozapine is recognized as the drug of choice for treatment-refractory schizophrenia, but use may be limited because of strict monitoring requirements and adverse effects including severe neutropenia, seizures, and myocarditis. Loxapine is a first-generation antipsychotic with similarities to clozap...